Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kyla Chandler"'
Autor:
Alice Halliday, Anna E. Long, Holly E. Baum, Amy C. Thomas, Kathryn L. Shelley, Elizabeth Oliver, Kapil Gupta, Ore Francis, Maia Kavanagh Williamson, Natalie Di Bartolo, Matthew J. Randell, Yassin Ben-Khoud, Ilana Kelland, Georgina Mortimer, Olivia Ball, Charlie Plumptre, Kyla Chandler, Ulrike Obst, Massimiliano Secchi, Lorenzo Piemonti, Vito Lampasona, Joyce Smith, Michaela Gregorova, Lea Knezevic, Jane Metz, Rachael Barr, Begonia Morales-Aza, Jennifer Oliver, Lucy Collingwood, Benjamin Hitchings, Susan Ring, Linda Wooldridge, Laura Rivino, Nicholas Timpson, Jorgen McKernon, Peter Muir, Fergus Hamilton, David Arnold, Derek N. Woolfson, Anu Goenka, Andrew D. Davidson, Ashley M. Toye, Imre Berger, Mick Bailey, Kathleen M. Gillespie, Alistair J. K. Williams, Adam Finn
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Low-volume antibody assays can be used to track SARS-CoV-2 infection rates in settings where active testing for virus is limited and remote sampling is optimal. We developed 12 ELISAs detecting total or antibody isotypes to SARS-CoV-2 nucleocapsid, s
Externí odkaz:
https://doaj.org/article/305a69f5b981428bab7c739f99a8b141
Autor:
Lilianna Bakinowska, Tanwi Vartak, Thato Phuthego, Michelle Taylor, Kyla Chandler, Samuel T. Jerram, The Action LADA Consortium, The BOX Study Group, Steve Williams, Marc Feldmann, Desmond G. Johnston, Kashyap Amratlal Patel, Alistair JK Williams, Anna E. Long, R. David Leslie, Kathleen M. Gillespie
Objective Proteomic profiling can identify useful biomarkers. Monozygotic(MZ) twins, discordant for a condition represent an ideal test population. We aimed to investigate and validate proteomic profiling in twins with type 1 diabetes and in other we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37868e1fad0e6c1b873c74c5e3ebe779
https://doi.org/10.2337/figshare.21801124
https://doi.org/10.2337/figshare.21801124
Autor:
Peter Achenbach, Benjamin Thomas Gillard, Rebecca Wyatt, Anna E. Long, Cristina Brigatti, Lorenzo Piemonti, Deborah K. Shoemark, Ilaria Marzinotto, Kathleen M Gillespie, Kyla Chandler, Alistair J K Williams, Daniela Liberati, Vito Lampasona, Sian Grace
Publikováno v:
Wyatt, R, Brigatti, C, Liberati, D, Grace, S, Gillard, B, Long, A, Marzinotto, I, Shoemark, D, Chandler, K, Achenbach, P, Gillespie, K, Piemonti, L, Lampasona, V & Williams, A 2018, ' The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes ', Diabetic Medicine, vol. 35, no. 7, pp. 954-963 . https://doi.org/10.1111/dme.13628
Aims: Glutamate decarboxylase (GAD) antibodies are the most widely used predictive marker for Type 1 diabetes, but many individuals currently found to be GAD antibody-positive are unlikely to develop diabetes. We have shown previously that radioimmun
Autor:
John A. Todd, Polly J. Bingley, Neil Walker, Helen Stevens, Kyla Chandler, Deborah J. Smyth, Joanna M. M. Howson
Publikováno v:
Diabetes
OBJECTIVE A major feature of type 1 diabetes is the appearance of islet autoantibodies before diagnosis. However, although the genetics of type 1 diabetes is advanced, the genetics of islet autoantibodies needs further investigation. The primary susc
Publikováno v:
Journal of immunological methods. 314(1-2)
Insulin autoantibody (IAA) microassays are widely used for predicting type 1 diabetes. As levels of IAA are often low in type 1 diabetes, non-specific binding (NSB) needs to be minimised if assays are to achieve high analytical sensitivity. IAA micro